ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА

In 24 patients with type 1 and 2 diabetes and 12 donors was shown that in diabetes the Nox releasing of membrane of blood formations is significantly enhanced. This phenomenon is more pronounced in type 2 diabetes, indicating a greater violation of the stability of erythrocyte membranes (EM) and serum exosomes (SE). Under the influence of exogenous glucose releasing of Nox is further enhanced to a greater extent, in particular from SE. Influenced insulin in vitro releasing Nox in EM and SE also increases in. Based on a number of data , it has been suggested the possible role of Nox as the insulin receptor. It is shown that in the serum membranous structures of patients with type 1 diabetes treated with insulin, as well as the addition of insulin into the blood of patients with type 2 diabetes the releasing of Nox was significantly higher than in healthy donors. In the presence of Embryonal antitumor modulator of Mkrtchyan (EATM) the releasing of Nox is significantly inhibited, especially in patients with type 2 diabetes. Suppression of the Nox isoforms releasing of EM and SE in patients with diabetes under the influence EATM can be considered as a possible mechanism of its membrane stabilizing effect in vivo.

1. Агаджанова Е.М., Симонян М.А. Влияние эмбрионального противоопухолевого модулятора на уровень и активность металлопротеинов у крыс при стрептозотоциновом диабете// Медицина, наука и образование. 2011. № 9. С. 13–17.

2. Аметов А.С., Соловьёва О.Л. Окислительный стресс при сахарном диабете 2 типа и пути его коррекции// Проблемы эндокринологии. 2011. № 6. С. 52–56.

3. Дедов И.И., Балаболкин М.И., Мамаева Г.Г. Сахарный диабет: ангиопатии и окислительный стресс. Пособие для врачей. М., 2003, 86 с.

4. Мелконян Л.Г. Симонян Р.М., Секоян Э.С., Симонян М.А. Изменение NADPH-зависимой супероксид-продуцирующей и ферриHb-восстанавливающей активности цитохрома b558 из мембран клеток селезёнки и эритроцитов, индуцированные излучением различной природы // ДНАН РА. 2009. № 109 (3). С. 225–235.

5. Мкртчян Л.Н. Эмбриональный противоопухолевый модулятор Мкртчяна. Патент РФ № 2240810. Январь 2004 г.

6. Симонян Г.М., Симонян Р.М., Симонян М.А. Способ получения цитохромов b из мембран эритроцитов. Лицензия изобрет № 908 Армпатента. Ереван. 2001.

7. Симонян Р.М., Галоян К.А., Г.М.Симонян, Хачатрян А.Р., Бабаян М.А., Оксузян Г.Р., Симонян М.А. Ферригемоглобин индуцирует рилизинг NADPH-оксидазы мозговой ткани ex vivo: подавление этого процесса галармином // Нейрохимия. 2013. № 30 (3). С. 1–5.

8. Сираканян М.С., Симонян Г.М., Бабаян М.А., Симонян М.А. Характерные изменения уровня и активности антиоксидантных и прооксидантных металлопротеинов крови крыс при острой интоксикации ионами кальция // Вестник МАНЭБ. СПб., 2006. № 11 (3). С. 192–198.

9. Фесчян С.М., Симонян Р.М., Енгибарян А.А., Симонян М.А. Роль гемоглобина в процессе появления экстрацеллюлярной NADPH оксидазы в сыворотке донорской крови и асцитной жидкости яичника женщин // Вопр. теорет. клин. мед. 2012. № 15 (4). С. 12–16.

10. Aghajanov M.I., Vahedian V., Aghajanova E.M., Mkrtchyan L.N., Simonyan M.A. NADPH-dependent superoxide producing activity of the embryonic anti-tumor modulator (EATM) and inhibition of this activity by isoforms of NADPH-oxidases // Медицина, наука и образование. 2011 № 8. P. 4–8.

11. Aghajanova Y.M. Preventive antidiabetic action of Embryonal antitumor modulator of Mkrtchyan (EATM) // 3rd Internat. medical congress of Armenia. Together to Health. Yerevan. 2011. Vol. 93. P. 73. 12. Bedard K., Krause K.-H. The NOX Family of ROS-Generating NADPH oxidases: physiology and pathophysiology // Physiol. Rev. 2007. Vol. 87, № 1. P. 245–313.

12. Cho N., Morre D.J. Early developmental expression of a normally tumor-associated and drug-inhibited cellsurface-located NADH oxidase (ENOX2) in non-cancer cells // Cancer Immunol. Immunother. 2009. Vol. 58, № 4. P. 547–552.

13. Ferrera A., Rivera A., Romero J.R. Na/Mg exchange in functionally coupled to the insulin reseptor // J. Cell Physiol. 2004. Vol. 199, № 3. P. 434–440.

14. Gray S.P., Marco E.D., Okabe J., Szyndralewiez C., Heitz F., Montezano A.C. et al. NADPH Oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis // Circulation. 2013. Vol. 127. P. 1888–1902.

15. Ishizuka T., Hinata T., Watanabe Y. Superoxide induced by a high-glucose concentration attenuates production of angiogenic growth factors in hypoxic mouse mesenchymal stem cells // J. Endocrinol. 2011. Vol. 208, № 2. P. 147–159.

16. Kangralkar V.A., Patil S.D., Bandivadekar R.M. Oxidative stress and diabetes: a review // Int. J. Pharm. Applic. 2010. Vol. 1, № 1. P. 38–45.

17. Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues// Free Radiol. Biol. Med. 1996. Vol. 20, № 3. P. 463–466.

18. Loehneysen K., Noak D., Wood M.R., Friedman J.S., Knaus U.G. Structural inside into Nox4 and Nox2: motifs involved in function and cellular localization // Mol. Cell Biol. 2010. Vol. 30, № 4. P. 961–975.

19. Magnuson M.A., Kahn C.R. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction // Mol. Cell. 2000. Vol. 6. P. 87–97.

20. Marar T. Amelioration of glucose induced hemolysis of human erythrocytes by vitamin E // Chem. Biol. Interact. 2011. Vol. 193, № 2. P. 149–153.

21. Mkrtchyan L.N. On a new strategy of preventive oncology // Neurochem. Res. 2010. Vol. 35. P. 868–874.

22. Moussa S.A. Oxidative stress in diabetes mellitus // Romanian J. Biophys. 2008. Vol. 18, № 3. P. 225–236.

23. Nandhini T.A., Anuradha C.V. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose // Clin. Chim. Acta. 2003. Vol. 336, № 1–2. P. 129–135.

24. Porat Sh., Weinberg-Corem N., Tornovsky-Babaev Sh., Schyr-Ben-Haroush R. et al. Control of pancreatic β-cell regeneration by glucose metabolism // Cell. Metabol. 2011. Vol. 13. P. 440–449.

25. Rupp A.K., Rupp C., Keller S., Brase J.C., Ehehalt R. et al. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage // Gyn. Oncol. 2011. Vol. 122, № 2. P. 437–446.

26. Simonyan G.M., Simonyan R.M., Simonyan M.A., Galoyan A.A. Stimulation of the NADPH-dependent O2-producing and methemoglobin reducing activities of new isoforms of cytochromes b558 by PRP-1 and Gx-NH2 // Neurochem. Res. 2008. Vol. 33. P. 153–156.

27. Simonyan G.M., Galoyan K.A., Simonyan R.M., Simonyan M.A., Galoyan A.A. Proline rich polypeptide (PRP-1) increases the superoxideproducing and ferrihemoglobin reducing activities of cytochrome b558

28. isoforms from human lymphosarc. tissue cells // Neurochem. Res. 2011. Vol. 36, № 5. P. 739–745.

29. Simonyan M.A. Reduction of some organic and inorganic oxidants in alkaline media by superoxide dismutase and scaveng. of hydroxy radic // Biochem. Biophys. Res. Commun. 1982. Vol. 108, № 4. P. 1751–1756.

30. Takahashi S., Kimura S., Kaya H., Iizuka A., Wong H.L., Shimamoto K., Kuchitsu K. Reactive oxygen species production and activation mechanism of the rice NADPH oxidase OsRbohB // J. Biochem. 2012. Vol. 152, № 1. P. 37–43.

31. Tavadyan L.A., Galoian K.A., Harutunyan L.A., Tonikyan H.G., Galoyan A.A. Antioxidant and electron donating function of hypothalamic polypeptides: galarmin and Gx-NH2 // Neurochem. Res. 2010. Vol. 35, № 6. P. 947–952.

32. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulinproducing cells // Diabetes. 1997. Vol. 46, № 11. P. 1733–1742.

33. Vahedian V., Aghajanova Y.M., Simonyan M.A., Aghajanov M.I. The preventive effect of embryonic antitumor modulator (EATM) on the level and activity of metalloproteins in rats with streptozotocin-induced diabetes // The New Armenian Med. J. 2011. Vol. 4, № 4. P. 57–63.